首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Variations on a scaffold - Novel GABA(A) receptor modulators
【24h】

Variations on a scaffold - Novel GABA(A) receptor modulators

机译:脚手架的变化 - 新型GABA(A)受体调节剂

获取原文
获取原文并翻译 | 示例
           

摘要

Allosteric ligands of GABA(A) receptors exist in many different chemotypes owing to their great usefulness as therapeutics, with benzodiazepines being among the best known examples. Many allosteric binding sites have been described, among them a site at the extracellular interface between the alpha principal face and the beta complementary face (alpha+/beta-). Pyrazoloquinolinones have been shown to bind at alpha+/beta-binding sites of GABA(A) receptors, exerting chiefly positive allosteric modulation at this location. In order to further explore molecular determinants of this type of allosteric modulation, we synthesized a library of ligands based on the PQ pharmacophore employing a ring-chain bioisosteric approach. In this study we analyzed the structure-activity-relationship (SAR) of these novel ligands based on an azo-biaryl structural motif in alpha 1 beta 3 GABA(A) receptors, indicating interesting novel properties of the compound class. (C) 2019 The Authors. Published by Elsevier Masson SAS.
机译:由于其作为治疗剂的良好有用性,GABA(A)受体的颠振配体存在于许多不同的趋化物中,并且苯齐氮卓在最着名的例子中。已经描述了许多颠覆结合位点,其中在α主面和β互补面(α+ /β-)之间的细胞外界面处的部位。 Pyrazoloquinolinones已显示在阿尔法绑定+ /β-类结合GABA(A)受体的位点,在该位置上施加主要是正变构调节。为了进一步探讨这种变形调节类型的分子确定剂,我们基于采用环链生物致电剂方法的PQ Pharmacophore合成了一种配体文库。在该研究中,我们将这些新型配体的结构 - 活性 - 关系(SAR)基于α1β3gaba(A)受体中的偶氮 - 芳基结构基序,表明复合类的有趣新颖性质。 (c)2019年作者。由Elsevier Masson SA出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号